Specialty code 1835P1200X · Roseville, CA
NPI
1568809762
Since 2013
Specialty
Specialty code 1835P1200X
Code 1835P1200X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1 Medical Plaza Dr, Inpatient Pharmacy
Roseville, CA, 95661
Phone (916) 996-7230
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$383K
2,745 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Don K Tran prescribed most often to Medicare patients was Atorvastatin Calcium, with 401 prescriptions and refills. In total Don K Tran wrote 2,745 Medicare prescriptions that cost $383K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 401 | 1,325 | 155 | $4,813 |
| Metformin Hcl Er Metformin Hcl | 297 | 981 | 121 | $2,966 |
| Glimepiride Generic | 208 | 656 | 77 | $3,376 |
| Jardiance Empagliflozin | 198 | 645 | 74 | $125K |
| Ozempic Semaglutide | 180 | 185 | 27 | $133K |
| Metformin Hcl Generic | 133 | 443 | 51 | $1,751 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 118 | 347 | 59 | $2,641 |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 116 | 361 | 44 | $23K |
| Rosuvastatin Calcium Generic | 110 | 364 | 43 | $1,282 |
| Losartan Potassium Generic | 108 | 359 | 48 | $1,467 |
| Amlodipine Besylate Generic | 96 | 320 | 34 | $1,227 |
| Lisinopril Generic | 76 | 253 | 29 | $987 |
| Simvastatin Generic | 73 | 243 | 25 | $852 |
| Insulin Glargine-Yfgn Generic | 61 | 169 | 36 | $6,816 |
| Humulin N Insulin Nph Human Isophane | 48 | 139 | 27 | $6,013 |
Brand drugs: 747 claims; generic drugs: 1,814 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Don K Tran were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.